Age and surgical outcome of low-grade glioma in Sweden

Jakola, 2017, Surgical resection versus watchful waiting in low-grade gliomas, Ann Oncol, 28, 1942, 10.1093/annonc/mdx230

Capelle, 2013, Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases: clinical article, J Neurosurg, 118, 1157, 10.3171/2013.1.JNS121

Chang, 2008, Preoperative prognostic classification system for hemispheric low-grade gliomas in adults, J Neurosurg, 109, 817, 10.3171/JNS/2008/109/11/0817

Pignatti, 2002, “Prognostic factors for survival in adult patients with cerebral low-grade glioma”, (in eng), J Clin Oncol, 20, 2076, 10.1200/JCO.2002.08.121

Youland, 2017, Patterns of care and treatment outcomes in older adults with low grade glioma: a 50-year experience, J Neurooncol, 133, 339, 10.1007/s11060-017-2439-3

Mangiola, 2006, Glioblastoma multiforme in the elderly: a therapeutic challenge, J Neurooncol, 76, 159, 10.1007/s11060-005-4711-1

Mukerji, 2008, Treating high grade gliomas in the elderly: the end of ageism?, J Neurooncol, 86, 329, 10.1007/s11060-007-9476-2

Kaloshi, 2009, “Supratentorial low-grade gliomas in older patients”, (in eng), Neurology, 73, 2093, 10.1212/WNL.0b013e3181c6781e

Weller, 2017, “European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas”, (in eng), Lancet Oncol, 18, e315, 10.1016/S1470-2045(17)30194-8

Asklund, 2015, “Brain tumors in Sweden: data from a population-based registry 1999-2012”, (in eng), Acta Oncol, 54, 377, 10.3109/0284186X.2014.975369

Louis, 2007, The 2007 WHO classification of tumours of the central nervous system, Acta Neuropathol, 114, 97, 10.1007/s00401-007-0243-4

“National quality registry for Brain tumours - 2016 annual report http://www.cancercentrum.se/globalassets/cancerdiagnoser/hjarna/kvalitetsregister/nationell-kvalitetsregisterrapport-hjarntumorer-199932015.pdf

Chaichana, 2011, “Supratentorial glioblastoma multiforme: the role of surgical resection versus biopsy among older patients”, (in eng), Ann Surg Oncol, 18, 239, 10.1245/s10434-010-1242-6

Gallego Perez-Larraya, 2014, Management of elderly patients with gliomas, Oncologist, 19, 1258, 10.1634/theoncologist.2014-0170

Posti, 2015, “Presenting symptoms of glioma in adults”, (in eng), Acta Neurol Scand, 131, 88, 10.1111/ane.12285

Tanaka, 2013, “Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients”, (in eng), J Neurosurg, 118, 786, 10.3171/2012.10.JNS112268

Iwamoto, 2009, “Glioblastoma in the elderly: the Memorial Sloan-Kettering Cancer Center Experience (1997-2007)”, (in eng), Cancer, 115, 3758, 10.1002/cncr.24413

Soffietti, 1989, Prognostic factors in well-differentiated cerebral astrocytomas in the adult, Neurosurgery, 24, 686, 10.1227/00006123-198905000-00005

Claus, 2015, “Survival and low-grade glioma: the emergence of genetic information”, (in eng), Neurosurg Focus, 38, E6, 10.3171/2014.10.FOCUS12367

Solheim, 2012, “Incidence and causes of perioperative mortality after primary surgery for intracranial tumors: a national, population-based study”, (in eng), J Neurosurg, 116, 825, 10.3171/2011.12.JNS11339

Pallud, 2013, “Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas”, (in eng), Neuro Oncol, 15, 595, 10.1093/neuonc/nos331

Gulati, 2011, “The risk of getting worse: surgically acquired deficits, perioperative complications, and functional outcomes after primary resection of glioblastoma”, (in eng), World Neurosurg, 76, 572, 10.1016/j.wneu.2011.06.014

Smoll, 2012, “Relative survival of patients with supratentorial low-grade gliomas”, (in eng), Neuro Oncol, 14, 1062, 10.1093/neuonc/nos144

Mazurowski, 2017, “Radiogenomics of lower-grade glioma: algorithmically-assessed tumor shape is associated with tumor genomic subtypes and patient outcomes in a multi-institutional study with The Cancer Genome Atlas data”, (in eng), J Neurooncol, 133, 27, 10.1007/s11060-017-2420-1

Balss, 2008, “Analysis of the IDH1 codon 132 mutation in brain tumors”, (in eng), Acta Neuropathol, 116, 597, 10.1007/s00401-008-0455-2

Wang, 2015, Anatomical localization of isocitrate dehydrogenase 1 mutation: a voxel-based radiographic study of 146 low-grade gliomas, Eur J Neurol, 22, 348, 10.1111/ene.12578

Qi, 2014, “Isocitrate dehydrogenase mutation is associated with tumor location and magnetic resonance imaging characteristics in astrocytic neoplasms”, (in eng), Oncol Lett, 7, 1895, 10.3892/ol.2014.2013

Brat, 2015, “Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas”, (in eng), N Engl J Med, 372, 2481, 10.1056/NEJMoa1402121

Sun, 2013, “Prognostic significance of IDH mutation in adult low-grade gliomas: a meta-analysis”, (in eng), J Neurooncol, 113, 277, 10.1007/s11060-013-1107-5

Mukasa, 2012, “Significance of IDH mutations varies with tumor histology, grade, and genetics in Japanese glioma patients”, (in eng), Cancer Sci, 103, 587, 10.1111/j.1349-7006.2011.02175.x

Kim, 2010, “Molecular classification of low-grade diffuse gliomas”, (in eng), Am J Pathol, 177, 2708, 10.2353/ajpath.2010.100680

Yan, 2009, “IDH1 and IDH2 mutations in gliomas”, (in eng), N Engl J Med, 360, 765, 10.1056/NEJMoa0808710

Yu, 2017, “Noninvasive IDH1 mutation estimation based on a quantitative radiomics approach for grade II glioma”, (in eng), Eur Radiol, 27, 3509, 10.1007/s00330-016-4653-3

Olar, 2015, “IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas”, (in eng), Acta Neuropathol, 129, 585, 10.1007/s00401-015-1398-z

Mandonnet, 2017, Biomathematical Modeling of DLGG Behavior, 2, 651

Wang, 2009, “Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel bio-mathematical model”, (in eng), Cancer Res, 69, 9133, 10.1158/0008-5472.CAN-08-3863

Schomas, 2009, Low-grade gliomas in older patients: long-term follow-up from Mayo Clinic, Cancer, 115, 3969, 10.1002/cncr.24444

Buckner, 2016, Radiation plus procarbazine, CCNU, and vincristine in low-grade glioma, N Engl J Med, 374, 1344, 10.1056/NEJMoa1500925

Bauman, 1999, “Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis”, (in eng), Int J Radiat Oncol Biol Phys, 45, 923, 10.1016/S0360-3016(99)00284-9

Smith, 2008, “Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas”, (in eng), J Clin Oncol, 26, 1338, 10.1200/JCO.2007.13.9337

Kydd, 2015, Ageism and age discrimination in health care: Fact or fiction? A narrative review of the literature, Maturitas, 81, 432, 10.1016/j.maturitas.2015.05.002

Brandes, 2003, A prospective study on glioblastoma in the elderly, Cancer, 97, 657, 10.1002/cncr.11097

Hutchins, 1999, “Underrepresentation of patients 65 years of age or older in cancer-treatment trials”, (in eng), N Engl J Med, 341, 2061, 10.1056/NEJM199912303412706

Gross, 2005, “Enrolling older persons in cancer trials: the effect of sociodemographic, protocol, and recruitment center characteristics”, (in eng), J Clin Oncol, 23, 4755, 10.1200/JCO.2005.14.365

Weller, 2011, “Geriatric neuro-oncology: from mythology to biology”, (in eng), Curr Opin Neurol, 24, 599, 10.1097/WCO.0b013e32834c4967

Pallud, 2009, “Prognostic significance of imaging contrast enhancement for WHO grade II gliomas”, (in eng), Neuro Oncol, 11, 176, 10.1215/15228517-2008-066

Jackson, 2001, “Limitations of stereotactic biopsy in the initial management of gliomas”, (in eng), Neuro Oncol, 3, 193, 10.1093/neuonc/3.3.193

Gulati, 2012, “Survival and treatment patterns of glioblastoma in the elderly: a population-based study”, (in eng), World Neurosurg, 78, 518, 10.1016/j.wneu.2011.12.008

Pallud, 2006, “Prognostic value of initial magnetic resonance imaging growth rates for World Health Organization grade II gliomas”, (in eng), Ann Neurol, 60, 380, 10.1002/ana.20946